10.12 DRCR.net Protocol T


A total of 660 participants from 89 clinical sites in the U.S. were completed the study. Randomization was as follows: 224 participants in the aflibercept 2.0 mg arm, 218 in the bevacizumab 1.25 mg arm, and 218 in the ranibizumab 0.3 mg arm.

Quiz Module 10.12

1. The Protocol T study examined the comparative effectiveness of which of the following?

2. The study found that when visual acuity is 20/40 or better, there is little difference between the drugs, but at 20/50 or worse which one is more effective?